Johanne Tremblay
Fondateur chez Prognomix, Inc.
Profil
Johanne Tremblay is the founder of Prognomix, Inc. She currently holds three positions as a Director at Medpharmgene, Inc., and as a Professor at both the Centre Hospitalier de l'Universite de Montreal and the University of Montréal.
She obtained a doctorate degree from the University of Montréal in 1982.
Postes actifs de Johanne Tremblay
| Sociétés | Poste | Début |
|---|---|---|
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Fondateur | - |
| University of Montréal | Corporate Officer/Principal | - |
Centre Hospitalier de l'Universite de Montreal
 Centre Hospitalier de l'Universite de Montreal Hospital/Nursing ManagementHealth Services Centre Hospitalier de lUniversite de Montreal owns and operates general hospitals. The firm provides inpatient and ambulatory care to its immediate urban clientele and specialized & ultra specialized services. The company was founded in 1995 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - |
Medpharmgene, Inc.
 Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Medpharmgene, Inc. provides commercial physical research services. The private company is based in Montréal, Canada and was founded in 2001. | Directeur/Membre du Conseil | - |
Formation de Johanne Tremblay
| University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Centre Hospitalier de l'Universite de Montreal
Centre Hospitalier de l'Universite de Montreal Hospital/Nursing ManagementHealth Services Centre Hospitalier de lUniversite de Montreal owns and operates general hospitals. The firm provides inpatient and ambulatory care to its immediate urban clientele and specialized & ultra specialized services. The company was founded in 1995 and is headquartered in Montreal, Canada. | Health Services |
Medpharmgene, Inc.
Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Medpharmgene, Inc. provides commercial physical research services. The private company is based in Montréal, Canada and was founded in 2001. | Commercial Services |
